(function(){var loadHandler=window['sl_{66E93C28-0859-4043-94A9-608E5C83AD92}'];loadHandler&&loadHandler(0, '<div id="spr0_35992"><div id="spr1_35992" class="kern"><img id="img37_35992" src="data/img34.jpg" width="1024px" height="768px" alt="" style="left:0px;top:0px;"/></div><div id="spr2_35992" class="kern"><div id="spr3_35992" style="left:-0.083px;"><img id="img0_35992" src="data/img0.jpg" width="1024" height="768" alt="C:\\Users\\Jen\\Dropbox\\Launchpad\\Seebri\\PowerPoint Seebri\\3_2_1_firsttab.jpg" style="left:0.083px;top:-0.042px;"/></div><div id="spr4_35992" style="left:377px;top:153px;"><img id="img1_35992" src="data/img1.png" width="126" height="14" alt="Why cycle ergometry?"/></div><div id="spr5_35992" style="left:110px;top:155px;"><img id="img2_35992" src="data/img2.png" width="200" height="14" alt="Improved exercise endurance time"/></div><div id="spr6_35992" style="left:590px;top:157px;"><img id="img3_35992" src="data/img3.png" width="83" height="13" alt="Why Exercise?"/></div><div id="spr7_35992" style="left:758px;top:504px;"><img id="img4_35992" src="data/img4.png" width="110" height="47" alt="ADD"/></div><div id="spr8_35992" style="left:867.373px;top:496.44px;"><div id="svg0_35992" style="left:3.781px;"><svg width="142" height="43" viewBox="0 0 142 43"><path fill="none" d="M0,0 h141.505 v42.002 h-141.505 Z"/></svg></div><div id="spr9_35992" style="left:9.627px;top:6.56px;"><img id="img5_35992" src="data/img5.png" width="127" height="29" alt="EXERCISE TOLERANCE BACK 4,6"/></div><div id="svg1_35992" style="top:43.1px;"><svg width="146" height="16" viewBox="0 0 146 16"><path fill="none" d="M0,0 h145.285 v15.347 h-145.285 Z"/></svg></div><div id="spr10_35992" style="left:4.627px;top:47.56px;"><img id="img6_35992" src="data/img6.png" width="135" height="6" alt="WITH ONCE-DAILY SEEBRI BREEZHALER"/></div></div><div id="spr11_35992" style="left:119px;top:46px;"><img id="img7_35992" src="data/img7.png" width="815" height="62" alt="SIGNIFICANT IMPROVEMENTS IN EXERCISE TOLERANCE WITH ONCE-DAILY SEEBRI® BREEZHALER® COMPARED WTH PLACEBO4,6"/></div><div id="spr12_35992" style="left:634px;top:586px;"><img id="img8_35992" src="data/img8.png" width="75" height="14" alt="Study Design"/></div><div id="spr13_35992" style="left:346px;top:718px;"><img id="img9_35992" src="data/img9.png" width="74" height="15" alt="REFERENCES"/></div><a id="hl0_35992" href="veeva:gotoSlide(seebri_en_0_0.zip)" title="veeva:gotoSlide(seebri_en_0_0.zip)" target="_blank" onclick="return document.getElementById(\'coreSpr_10848573\').getCore().gotoLink(this);" style="left:0px;top:641.009px;"><div id="svg2_35992" style="left:0px;top:0px;"><svg width="218" height="127" viewBox="0 0 218 127"><path fill="#000000" fill-opacity="0" d="M0,0 h217.116 v126.991 h-217.116 Z"/></svg></div></a><a id="hl1_35992" href="veeva:gotoSlide(seebri_en_10_1_1.zip)" title="veeva:gotoSlide(seebri_en_10_1_1.zip)" target="_blank" onclick="return document.getElementById(\'coreSpr_10848573\').getCore().gotoLink(this);" style="left:313.52px;top:678.804px;"><div id="svg3_35992" style="left:0px;top:0px;"><svg width="131" height="90" viewBox="0 0 131 90"><path fill="#000000" fill-opacity="0" d="M0,0 h130.429 v89.196 h-130.429 Z"/></svg></div></a><a id="hl2_35992" href="veeva:gotoSlide(seebri_en_7_1_1.zip)" title="veeva:gotoSlide(seebri_en_7_1_1.zip)" target="_blank" onclick="return document.getElementById(\'coreSpr_10848573\').getCore().gotoLink(this);" style="left:458.127px;top:680.44px;"><div id="svg4_35992" style="left:0px;top:0px;"><svg width="277" height="90" viewBox="0 0 277 90"><path fill="#000000" fill-opacity="0" d="M0,0 h276.926 v89.196 h-276.926 Z"/></svg></div></a><a id="hl3_35992" href="veeva:gotoSlide(seebri_en_11_0.zip)" title="veeva:gotoSlide(seebri_en_11_0.zip)" target="_blank" onclick="return document.getElementById(\'coreSpr_10848573\').getCore().gotoLink(this);" style="left:827.677px;top:656.127px;"><div id="svg5_35992" style="left:0px;top:0px;"><svg width="197" height="112" viewBox="0 0 197 112"><path fill="#000000" fill-opacity="0" d="M0,0 h196.323 v111.769 h-196.323 Z"/></svg></div></a><div id="spr14_35992" style="left:186.872px;top:549.046px;"><img id="img10_35992" src="data/img10.png" width="545" height="19" alt="C:\\Work\\Seebri Global Assets\\137261 HTML files\\popup_banner1.png" style="left:-0.168px;top:0px;"/></div><div id="spr15_35992" style="left:710.193px;top:556.596px;"><img id="img11_35992" src="data/img11.png" width="11" height="6" alt="C:\\Work\\Seebri Global Assets\\137261 HTML files\\137261 HTML files\\SeebriHidden\\global_seebri_en_rapid_3_1_1_PROJECTCODE\\global_seebri_en_rapid_3_1_1_PROJECTCODE\\local\\global_seebri_en_rapid_3_1_1_PROJECTCODE\\assets\\flyout_up.png" style="left:0.001px;top:-0px;"/></div><div id="spr16_35992" style="left:202px;top:388px;"><img id="img12_35992" src="data/img12.png" width="118" height="78" alt="43-second improvement\
vs placebo\
   "/></div><div id="spr17_35992" style="left:219px;top:474px;"><img id="img13_35992" src="data/img13.png" width="76" height="16" alt="(P&lt;0.001)"/></div><div id="spr18_35992" style="left:508px;top:388px;"><img id="img14_35992" src="data/img14.png" width="118" height="78" alt="89-second improvement\
vs placebo\
   "/></div><div id="spr19_35992" style="left:525px;top:474px;"><img id="img15_35992" src="data/img13.png" width="76" height="16" alt="(P&lt;0.001)"/></div><div id="spr20_35992" style="left:219px;top:534px;"><img id="img16_35992" src="data/img15.png" width="38" height="16" alt="Day 1"/></div><div id="spr21_35992" style="left:129px;top:216px;"><img id="img17_35992" src="data/img16.png" width="538" height="38" alt="In GLOW3, a 3-week  trial designed to measure exercise *tolerance, Seebri Breezhaler, dosed in the morning improved exercise endurance time4,6*"/></div><div id="spr22_35992" style="left:502px;top:531px;"><img id="img18_35992" src="data/img17.png" width="127" height="16" alt="Day 21/study end"/></div><div id="svg6_35992" style="left:587.611px;top:576.772px;"><svg width="159" height="38" viewBox="0 0 159 38"><path fill="#ffffff" fill-opacity="0.012" d="M0,0 h158.784 v37.779 h-158.784 Z"/></svg></div><div id="svg7_35992" style="left:360.777px;top:138.33px;"><svg width="182" height="46" viewBox="0 0 182 46"><path fill="#ffffff" fill-opacity="0.012" d="M0,0 h181.467 v45.354 h-181.467 Z"/></svg></div><div id="svg8_35992" style="left:564.928px;top:138.33px;"><svg width="142" height="46" viewBox="0 0 142 46"><path fill="#ffffff" fill-opacity="0.008" d="M0,0 h141.771 v45.354 h-141.771 Z"/></svg></div><a id="hl4_35992" href="veeva:gotoSlide(seebri_en_3_2_2.zip)" title="veeva:gotoSlide(seebri_en_3_2_2.zip)" target="_blank" onclick="return document.getElementById(\'coreSpr_10848573\').getCore().gotoLink(this);" style="left:940.016px;top:308.409px;"><div id="svg9_35992" style="left:0px;top:0px;"><svg width="84" height="118" viewBox="0 0 84 118"><path fill="#000000" fill-opacity="0" d="M0,0 h83.984 v117.166 h-83.984 Z"/></svg></div></a><div id="spr23_35992" style="left:473px;top:718px;"><img id="img19_35992" src="data/img18.png" width="198" height="15" alt="LOCAL PRESCRIBING INFORMATION"/></div><div id="spr24_35992" style="left:777px;top:435px;"><img id="img20_35992" src="data/img19.png" width="180" height="24" alt="*Treatments were taken once daily in the mornings between 8 AM and 11 AM.6"/></div><div id="spr25_35992" style="left:-0.361px;top:0.458px;"><img id="img21_35992" src="data/img20.png" width="1024" height="768" alt="C:\\College\\Dropbox\\Launchpad (2)\\Seebri\\PowerPoint Seebri\\PPT_With_Editable_Text\\3-2-1\\tab2_complete.png" style="top:-0.104px;"/></div><div id="spr26_35992" style="left:-0.351px;top:1.004px;"><img id="img22_35992" src="data/img21.png" width="1024" height="768" alt="C:\\College\\Dropbox\\Launchpad (2)\\Seebri\\PowerPoint Seebri\\PPT_With_Editable_Text\\3-2-1\\tab3_complete.png" style="top:-0.104px;"/></div><div id="spr27_35992" style="left:380px;top:155px;"><img id="img23_35992" src="data/img22.png" width="121" height="14" alt="Why cycle ergometry"/></div><div id="spr28_35992" style="left:600px;top:155px;"><img id="img24_35992" src="data/img3.png" width="83" height="13" alt="Why Exercise?"/></div><div id="spr29_35992" style="left:110px;top:156px;"><img id="img25_35992" src="data/img23.png" width="200" height="14" alt="Improved exercise endurance time"/></div><div id="spr30_35992" style="left:107px;top:280px;"><img id="img26_35992" src="data/img24.png" width="324" height="124" alt="Cycle ergometry, a standardised, clinical diagnostic test, was chosen because it requires a more strenuous effort from the patient. Once their maximum workload was determined, patients were administered either once-daily Seebri Breezhaler or placebo and tested cycling at 80% of their maximum workload at several time points to determine how long they were able to perform.6 "/></div><div id="spr31_35992" style="left:134px;top:277px;"><img id="img27_35992" src="data/img25.png" width="512" height="69" alt="Limitation in exercise capacity is a key feature of COPD and is one of the main factors to negatively impact patients’ quality of life. Improving exercise tolerance, lung hyperinflation, and dyspnea are therefore important goals in the therapeutic management of COPD as it will help patients be more active during the day. 6 "/></div><div id="spr32_35992" style="left:599px;top:157px;"><img id="img28_35992" src="data/img26.png" width="83" height="13" alt="Why Exercise?"/></div><div id="spr33_35992" style="left:375px;top:156px;"><img id="img29_35992" src="data/img1.png" width="126" height="14" alt="Why cycle ergometry?"/></div><div id="spr34_35992" style="left:105px;top:157px;"><img id="img30_35992" src="data/img27.png" width="200" height="14" alt="Improved exercise endurance time"/></div><div id="spr35_35992" style="top:0.104px;"><img id="img31_35992" src="data/img28.png" width="1024" height="768" alt="C:\\College\\Dropbox\\Launchpad (2)\\Seebri\\PowerPoint Seebri\\PPT_With_Editable_Text\\3-2-1\\flyout.png" style="top:-0.104px;"/></div><div id="svg10_35992" style="left:595.172px;top:574.24px;"><svg width="159" height="38" viewBox="0 0 159 38"><path fill="#ffffff" fill-opacity="0.008" d="M0,0 h158.784 v37.779 h-158.784 Z"/></svg></div><div id="spr36_35992" style="left:636px;top:587px;"><img id="img32_35992" src="data/img29.png" width="75" height="14" alt="Study Design"/></div><div id="svg11_35992" style="left:614.075px;top:566.375px;"><svg width="121" height="52" viewBox="0 0 121 52"><path fill="#ffffff" fill-opacity="0.012" d="M0,0 h120.173 v51.957 h-120.173 Z"/></svg></div><div id="spr37_35992" style="left:210px;top:317px;"><img id="img33_35992" src="data/img30.png" width="502" height="118" alt="GLOW2 (GLYCOPYRRONIUM BROMIDE IN COPD AIRWAYS-2): A 52-week treatment, randomized, double-blinded, placebo-controlled, with open-label tiotropium 18 µg, parallel-group study to assess the efficacy, safety, and tolerability of once-daily glycopyrronium 50 µg in 1066 patients (glycopyrronium n=529, open-label tiotropium n=268, placebo n=269) with chronic obstructive pulmonary disease. The primary objective was to confirm that glycopyrronium compared with placebo significantly increase mean 24-hour post-dose (trough) FEV1  following 12 weeks of treatment in patients with moderate to severe COPD. As exploratory analyses, open-label tiotropium was comapared with glycopyrronium and placebo for all study objectives.5"/></div><div id="spr38_35992" style="left:214px;top:457px;"><img id="img34_35992" src="data/img31.png" width="356" height="26" alt="For information on Seebri Breezhaler dose expression, please refer to full prescribing information."/></div><div id="spr39_35992" style="left:213px;top:520px;"><img id="img35_35992" src="data/img32.png" width="388" height="26" alt="Treatments were taken once daily in the mornings between 8 AM and 11 AM and patients were tested within 1 hour of dose administration. 6"/></div><div id="spr40_35992" style="left:711.116px;top:291.071px;"><img id="img36_35992" src="data/img33.png" width="11" height="6" alt="C:\\Work\\Seebri Global Assets\\137261 HTML files\\137261 HTML files\\SeebriHidden\\global_seebri_en_rapid_3_1_1_PROJECTCODE\\global_seebri_en_rapid_3_1_1_PROJECTCODE\\local\\global_seebri_en_rapid_3_1_1_PROJECTCODE\\assets\\flyout_down.png" style="left:0.001px;top:-0px;"/></div></div></div>');})();